Tango Therapeutics Inc (TNGX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TNGX? Forum Prognose

Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	53.81	3.181	5.392	4.117
Operating Expenses	5.35% 41.86	39.74	44.15	47.92	45.03
Benefits Costs and Expenses	2.29% 38.80	37.94	42.00	45.23	41.74
Costs And Expenses	2.29% 38.80	37.94	42.00	45.23	41.74
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	397.50% -41.86	14.07	-40.97	-42.53	-40.91
Net Interest Income/Expense	53.14% 1.68	1.097	1.239	1.614	1.813
Nonoperating Income/Loss	69.81% 3.06	1.802	2.149	2.688	3.289
Income/Loss From Continuing Operations Before Tax	344.45% -38.80	15.87	-38.82	-39.84	-37.62
Income Tax Expense/Benefit	450.00% -0.055	-0.01	0.035	0.034	0.049
Income/Loss From Continuing Operations After Tax	343.95% -38.75	15.88	-38.85	-39.88	-37.67
Net Income/Loss	343.95% -38.75	15.88	-38.85	-39.88	-37.67
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	95.13% 5.4045	110.97	110.54	110.30	0.2367
Diluted Average Shares	95.41% 5.4045	117.78	110.54	110.30	0.2367
Basic Earnings Per Share	314.29% -0.30	0.14	-0.35	-0.36	-0.34
Diluted Earnings Per Share	330.77% -0.30	0.13	-0.35	-0.36	-0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%